RUNX3 and prostate carcinoma: To further determine the effect of restored RUNX3 expression on angiogenic potential of human prostate cancer cells, the angiogenic potentials of the supernatant of PC3 and DU145 cells transfected with pFlag-control or pFlag-RUNX3 were determined by endothelial cell proliferation assay and tube formation assay.